Should You Invest in AbbVie (ABBV)?
Harding Loevner, an asset management company, released its “Global Equity Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,991,100 | $476,691,607 | +6% | 0.1% | |
| 2. | Citadel Investment Group Ken Griffin | 2,264,343 | $360,868,344 | +373% | 0.07% |
| 3. | 2,224,600 | $354,534,502 | -11% | 0.07% | |
| 4. | Diamond Hill Capital Ric Dillon | 1,325,693 | $211,275,699 | -2% | 0.98% |
| 5. | AQR Capital Management Cliff Asness | 1,194,224 | $188,758,971 | -17% | 0.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $150.50 | 6,222 | 34,483 | 2023-02-17 | Filing | ||
| $165.00 | 6,130 | 35,330 | 2023-04-25 | Filing | ||
| $162.04 | 500 | 35,330 | 2023-04-17 | Filing | ||
| $161.64 | 6,999 | 35,830 | 2023-04-17 | Filing | ||
| $160.03 | 15,002 | 42,829 | 2023-04-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 160,447,093 | $25,570,453,212 | 0.65% | |
| 2. | 138,721,510 | $22,108,047,091 | 0.65% | |
| 3. | 77,026,437 | $12,275,679,624 | 0.69% | |
| 4. | 42,748,362 | $6,812,716,986 | 1.75% | |
| 5. | 35,714,367 | $5,691,795,305 | 1.62% |
News See All
S&P 500 Dividend Aristocrats List: Top 10 Picks by Hedge Funds
In this article, we will discuss the 10 best dividend aristocrat stocks sorted by hedge fund popularity.
5 Best Healthcare Stocks To Buy Now
On May 19, AbbVie Inc. (NYSE:ABBV) announced that the US Food and Drug Administration (FDA) had approved its blood cancer therapy for adult patients.
Louis Navellier's 2023 Portfolio: 15 Growth Stocks to Watch
In this article, we discuss 15 growth stocks to watch in Louis Navellier's 2023 portfolio.
5 Best Biotech Stocks To Buy According To Hedge Funds
Eli Lilly and Company (NYSE:LLY) is a major pharmaceutical company in the U.S.
5 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 5 best healthcare dividend stocks to buy.
5 Stocks Warren Buffett Sold
Berkshire Hathaway dropped Bristol-Myers Squibb Company (NYSE:BMY) in the first quarter of 2022 after years of holding.
Here's Why Baron Health Care Fund Trimmed AbbVie (ABBV)
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Analysts Are Cutting Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
States With the Lowest to Highest Capital Gains Tax Rate
In this article, we will take a look at states with the lowest to highest capital gains tax rates.
Billionaire Hedge Funds
